Interpretation of Hepatitis B Surface Antibody Result <3.5 mIU/mL
Your Hepatitis B Surface Antibody (anti-HBs) result of <3.5 mIU/mL indicates you are not immune to hepatitis B virus infection and require vaccination. 1
Understanding Your Result
- Anti-HBs level <10 mIU/mL indicates lack of protective immunity against hepatitis B virus (HBV) infection 1
- Your result of <3.5 mIU/mL falls below the protective threshold of 10 mIU/mL 1
- This result suggests either:
Recommended Intervention
If you have documentation of previous complete HepB vaccination:
- Receive one challenge dose of hepatitis B vaccine 1
- Check anti-HBs levels 4-8 weeks after this challenge dose 1
- If anti-HBs ≥10 mIU/mL after challenge dose, no further doses needed (indicates immune memory) 1
- If anti-HBs remains <10 mIU/mL after challenge dose, complete a second full vaccination series 1
If you have no documentation of previous HepB vaccination:
- Complete a full hepatitis B vaccination series 1
- HEPLISAV-B: Two-dose series at 0 and 1 month, OR
- ENGERIX-B or Recombivax HB: Three-dose series at 0,1, and 6 months, OR
- PreHevbrio: Three-dose series at 0,1, and 6 months 1
- Check anti-HBs levels 1-2 months after completing the series 1
Special Considerations
- Hepatitis B vaccination is now universally recommended for all adults aged 19-59 years 1
- Certain populations have higher risk of non-response to vaccination:
Monitoring After Vaccination
- After completing vaccination, anti-HBs levels should be checked 1-2 months after the last dose 1
- Protective immunity is defined as anti-HBs ≥10 mIU/mL 1
- For most healthy individuals, protection persists even if antibody levels decline over time 2
- Healthcare workers and immunocompromised individuals may require periodic monitoring of anti-HBs levels 1
Common Pitfalls to Avoid
- Don't confuse anti-HBs (surface antibody) with anti-HBc (core antibody) - they indicate different things 1
- Don't assume prior vaccination guarantees immunity - antibody levels can wane over time, especially in certain populations 3
- Don't delay vaccination if indicated - hepatitis B can lead to serious liver disease 1
- Don't skip post-vaccination testing if you're in a high-risk group (healthcare workers, immunocompromised) 1